Funded Tech Companies
Genoa Pharmaceuticals
Headquartered in Seattle, Genoa Pharmaceuticals is venture-backed, with investment from TPG Biotech, Novo Ventures and F-Prime Capital.
Company Overview
Company Name
Genoa Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
701 Pike St. 1500
Seattle, WA 98101
USA
Seattle, WA 98101
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Genoa is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (Aerodone) for the treatment of IPF.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/16/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce Montgomery
Chief Scientific Officer
Mark Surber
VP - Finance
Nancy McKinley
Company Investors
- TPG Biotech
- Novo Ventures
- F-Prime Capital
- RiverVest Venture Partners
- Edmond de Rothschild Investment Partners
- Private Investors (Heather Preston)
- Private Investors (Jonathan Leff)
- Private Investors (Ketan Patel)
- Private Investors (Naveed Siddiqi)
- Private Investors (Niall O'Donnell)
- Private Investors (Tiba Aynechi)
Browse more funded tech companies:
Genoa Healthcare | Genocea Biosciences
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs